Cargando…

Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics

Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a lite...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Jiyun, Kim, Sungha, Kim, Pyung-Wha, Lee, Hesol, Ko, Mi Mi, Jang, Soobin, Lee, Myeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081499/
https://www.ncbi.nlm.nih.gov/pubmed/35548368
http://dx.doi.org/10.3389/fphar.2022.868662
_version_ 1784702999398973440
author Cha, Jiyun
Kim, Sungha
Kim, Pyung-Wha
Lee, Hesol
Ko, Mi Mi
Jang, Soobin
Lee, Myeong Soo
author_facet Cha, Jiyun
Kim, Sungha
Kim, Pyung-Wha
Lee, Hesol
Ko, Mi Mi
Jang, Soobin
Lee, Myeong Soo
author_sort Cha, Jiyun
collection PubMed
description Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a literature review and defined the list of outcomes and effect modifiers for the core outcome set (COS) questionnaire. Three rounds of modified Delphi consensus exercises with experts were conducted online for suitability assessment, and one round of a modified Delphi consensus exercise with primary clinicians was conducted for feasibility assessment. Results: The review identified 17 outcomes and 16 effect modifiers; moreover, six outcomes and one effect modifier were suggested by the experts. The final COS comprised 8 outcomes and 12 effect modifiers for history taking, and experts listed 13 major symptoms of stroke sequelae for symptom assessment. The clinicians agreed on the feasibility of the COS. Conclusion: This COS will help primary care researchers assess the effectiveness of pharmacotherapy, including HM, for elderly patients with stroke sequelae. Future studies should focus on reflecting the opinions of all stakeholders.
format Online
Article
Text
id pubmed-9081499
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90814992022-05-10 Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics Cha, Jiyun Kim, Sungha Kim, Pyung-Wha Lee, Hesol Ko, Mi Mi Jang, Soobin Lee, Myeong Soo Front Pharmacol Pharmacology Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a literature review and defined the list of outcomes and effect modifiers for the core outcome set (COS) questionnaire. Three rounds of modified Delphi consensus exercises with experts were conducted online for suitability assessment, and one round of a modified Delphi consensus exercise with primary clinicians was conducted for feasibility assessment. Results: The review identified 17 outcomes and 16 effect modifiers; moreover, six outcomes and one effect modifier were suggested by the experts. The final COS comprised 8 outcomes and 12 effect modifiers for history taking, and experts listed 13 major symptoms of stroke sequelae for symptom assessment. The clinicians agreed on the feasibility of the COS. Conclusion: This COS will help primary care researchers assess the effectiveness of pharmacotherapy, including HM, for elderly patients with stroke sequelae. Future studies should focus on reflecting the opinions of all stakeholders. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9081499/ /pubmed/35548368 http://dx.doi.org/10.3389/fphar.2022.868662 Text en Copyright © 2022 Cha, Kim, Kim, Lee, Ko, Jang and Lee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Cha, Jiyun
Kim, Sungha
Kim, Pyung-Wha
Lee, Hesol
Ko, Mi Mi
Jang, Soobin
Lee, Myeong Soo
Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title_full Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title_fullStr Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title_full_unstemmed Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title_short Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
title_sort development of the korean medicine core outcome set for stroke sequelae: herbal medicine treatment of elderly patients with stroke sequelae in primary clinics
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081499/
https://www.ncbi.nlm.nih.gov/pubmed/35548368
http://dx.doi.org/10.3389/fphar.2022.868662
work_keys_str_mv AT chajiyun developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT kimsungha developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT kimpyungwha developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT leehesol developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT komimi developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT jangsoobin developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics
AT leemyeongsoo developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics